Tag: China
Horwin introduces first e-motorcycle of Senmenti series at EICMA 2022
Horwin, a Chinese electric two-wheeler manufacturer, has unveiled the first e-motorcycle model Senmenti 0 of the Horwin Senmenti series. Senmenti 0, a high-performance e-motorcycle, features ... Read More
Chinese automaker Chijet Motor to go public via merger with JWAC
Chijet Motor Company, a Chinese automaker, has signed a merger agreement with Jupiter Wellness Acquisition (JWAC), a special purpose acquisition company (SPAC), with an intention ... Read More
China Resources Beer to buy over 55% stake in Guizhou Jinsha Winery for $1.6bn
China Resources Beer (Holdings) Company has agreed to acquire a stake of 55.19% in Guizhou Jinsha Jiaojiu Winery Industry Co., for a total consideration of ... Read More
IAMGOLD to sell Rosebel Gold Mines stake in Suriname to Zijin Mining
Canadian gold miner IAMGOLD Corporation has agreed to sell its 95% interest in Rosebel Gold Mines to Chinese mining company Zijin Mining Group for $360 ... Read More
Kintor Pharmaceutical completes patient enrollment in KX-826 phase 2 trial
Kintor Pharmaceutical said that it has wrapped up patient enrollment for the phase 2 clinical trial of KX-826 (pyrilutamide) in China for the treatment of ... Read More
Gravita India begins production from aluminium recycling plant in Senegal
Gravita India Limited, an Indian recycling company, announced that it has begun commercial production of aluminium at its new recycling plant in Senegal through its ... Read More
Icape acquires Danish PCB solutions provider MON PRINT
Icape Holding, a technology distributor of printed circuit boards (PCBs), has acquired MON PRINT, a PCB solutions provider in Denmark, for €0.7 million. Established in ... Read More
Innovent Biologics, Sanofi to expedite development of cancer drugs in China
Chinese biopharma company Innovent Biologics and French pharma giant Sanofi have entered into a partnership that aims to bring innovative drugs to patients in China ... Read More
CANbridge Pharmaceuticals begins CAN103 phase 1/2 trial in Gaucher disease
CANbridge Pharmaceuticals said that it has dosed the first patient in a phase 1/2 trial of CAN103 in treatment-naïve patients in China having Gaucher disease ... Read More
HUTCHMED begins HMPL-A83 phase 1 trial in advanced malignant neoplasms
HUTCHMED (China) has launched a phase 1 clinical trial of its oncology drug candidate HMPL-A83 in China in patients having advanced malignant neoplasms. HMPL-A83 is ... Read More
